Infant Bacterial Therapeutics AB News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

05.11.20	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2020 (GlobeNewswire)
14.08.20	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2020 (GlobeNewswire)
16.06.20	Annual General Meeting of Infant Bacterial Therapeutics (GlobeNewswire)
18.05.20	Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics (GlobeNewswire)
11.05.20	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1-March 31, 2020 (GlobeNewswire)
03.04.20	Infant Bacterial Therapeutics publishes Annual Report for 2019 (GlobeNewswire)
03.04.20	Infant Bacterial Therapeutics AB postpones Annual General Meeting (GlobeNewswire)
11.02.20	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2019 (GlobeNewswire)
11.11.19	Infant Bacterial Therapeutics AB (publ) announces that the Nomination Committee is appointed for the Annual General Meeting 2020 (GlobeNewswire)
07.11.19	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2019 (GlobeNewswire)
05.11.19	Lilian Wikström Ph.D. has requested to resign from the Board of Directors of Infant Bacterial Therapeutics AB (GlobeNewswire)
21.08.19	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2019 (GlobeNewswire)
04.07.19	Infant Bacterial Therapeutics has recruited the first patient in the pivotal Phase III clinical study (GlobeNewswire)
19.05.19	FDA and Infant Bacterial Therapeutics agree on the design of Phase III study (GlobeNewswire)
06.05.19	Annual General Meeting of Infant Bacterial Therapeutics (GlobeNewswire)
06.05.19	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 31, 2019 (GlobeNewswire)
05.04.19	Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) (GlobeNewswire)
04.04.19	IBT publishes annual report for 2018 (GlobeNewswire)
05.03.19	Infant Bacterial Therapeutics AB announces first distribution agreement (GlobeNewswire)
08.02.19	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2018 (GlobeNewswire)
21.11.18	The Phase III study protocol is modified after IBT’s meeting with the FDA (GlobeNewswire)
14.11.18	Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2018 (GlobeNewswire)
08.10.18	Infant Bacterial Therapeutics AB (publ) announces that the Nomination Committee is appointed for the Annual General Meeting 2019 (GlobeNewswire)
04.09.18	Infant Bacterial Therapeutics publishes prospectus in connection with the list change to Nasdaq Stockholm (GlobeNewswire)
30.08.18	Infant Bacterial Therapeutics has been approved for listing on the main market of Nasdaq Stockholm (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Infant Bacterial Therapeutics AB (B)

Aktien Top/Flop

Meistgelesene Nachrichten